Diterpenoid quinones |
1
|
Tanshindiol B |
6.80-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
4.85 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
2
|
17-Hydroxycryptotanshinone |
3.97-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
3
|
Isotanshinone IIA |
6.45-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
4
|
Trijuganone A |
4.31-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
5
|
Tanshinone IIB |
5.34-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
4.85 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
6
|
Przewaquinone A |
6.01-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
7
|
Przewaquinone B |
7.27-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
8
|
1-Ketoisocryptotanshinone |
5.65-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
9
|
15,16-Dihydrotanshinone I |
3.38-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
4.80 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
Induction of ARE luciferase and upregulation of Nrf2 protein level |
MDA-MB-231 cells |
[40] |
Induction of Nrf2, NQO1, and γ-GCS protein levels |
Human dermal fibroblasts. |
[41] |
10
|
1,2,15,16-Tetrahydrotanshinone I |
4.37-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
11
|
Cryptotanshinone |
3.61-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
5.07 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
Induction of ARE luciferase and upregulation of Nrf2 protein level |
MDA-MB-231 cells |
[40] |
Induction of ARE-luciferase activity |
Hep G2 cells |
[26] |
12
|
Tanshinone I |
2.60-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
5.90 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
Induction of ARE luciferase and upregulation of Nrf2 protein level |
MDA-MB-231 cells |
[40] |
Upregulation of Nrf2, HO-1, GCLC, and GCLM |
SH-SY5Y cells |
[42, 43] |
Induction of ARE-luciferase activity |
Hep G2 cells |
[26] |
Induction of Nrf2, NQO1, and γ-GCS protein levels |
Human dermal fibroblasts |
[41] |
13
|
RO-090680 |
3.06-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
14
|
Methylenetanshinquinone |
2.77-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
15
|
1,2-Didehydromilitirone |
3.79-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
1.04 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
16
|
Tanshinone IIA |
2.58-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
5.10 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
Upregulation of Nrf2, HO-1, and NQO-1 protein levels |
JB6 cells |
[44] |
Induction of ARE luciferase and upregulation of Nrf2 protein level |
MDA-MB-231 cells |
[40] |
Upregulation of Nrf2, NOQ-1, HO-1, GCLC, and GCLM protein levels |
Human aortic smooth muscle cells. |
[45] |
Induction of ARE-luciferase activity and upregulation of mRNA levels of GCLC, NQO1, and HO-1 |
Hepa G2 cells |
[26] |
Induction of Nrf2 and upregulation of mRNA and protein levels of HO-1, NQO1, and GCLC |
SH-SY5Y cells |
[46] |
17
|
Miltirone |
3.32-fold induction of ARE luciferase activity |
HEK 293 T cells |
[38] |
0.92 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
Enhancement of Nrf2 translocation and upregulation mRNA and protein levels of Nrf2, HO-1, and NQO1 |
EA.hy926 cells |
[47] |
18
|
17-Hydroxycryptotanshinone |
4.85 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
19
|
1-Oxomiltirone |
0.40 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
20
|
4-Methylenemiltirone |
0.46 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
21
|
1,2-Dihydrotanshinone I |
5.40 μM for 2-fold induction of QR activity |
Hepa 1c1c7 cells |
[39] |
|
Phenolic acids |
22
|
Danshensu |
Upregulation of mRNA and protein levels of Nrf2 |
Rat heart |
[48] |
23
|
Rosmarinic acid |
Upregulation of Nrf2 and HO-1 protein level |
Rat cochlea |
[49] |
24
|
Salvianolic acid A |
Induction of mRNA and protein levels of Nrf2 and HO-1 |
RPE cells |
[50, 51] |
25
|
Salvianolic acid B |
Induction of Nrf2 and HO-1 |
Rat lung tissue |
[52] |
Induction of Nrf2 protein level |
Rat primary neurons |
[53] |
Induction of Nrf2, HO-1, and GCLC protein levels |
Hepa G2 cells |
[54] |